Researchers at the Buck Institute used Axiom-2 blood samples to show spaceflight temporarily accelerated epigenetic aging, ...

Natera teams up with NVIDIA to train multimodal AI models, aiming to improve precision care through faster, scalable analysis ...

Cancer immunity and immunotherapy research increasingly recognizes that chronic inflammation is a major driver of tumorigenesis, yet the complex and dynamic ...

Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterised by remarkable cellular ...

At CES 2026, I tried six consumer exoskeletons and talked to an expert on medical exoskeletons. I'm not sure these devices ...

Two renowned prehistoric individuals were likely infected with a human papillomavirus that has been linked to several cancers ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

Bats are critical viral reservoirs that harbor viromes with a high risk of cross-species transmission. However, the diversity ...

The collaboration enables seamless integration of Owkin's advanced pathology analysis capabilities into Claude's AI platform, ...

After decades of teaching and research at leading global institutions such as Harvard University and the Massachusetts ...

AI safety and research company Anthropic announced the launch of Claude for Healthcare, a set of HIPAA-ready AI tools for ...

When the four-member crew of Axiom-2 launched into space in May 2023 their 10-day mission was chock full of experiments aimed at understanding human physiology. Results from some of those experiments, ...